Dhruv Chawla, MD
Clinical Cardiac Electrophysiology · Stockbridge, GANPI 1043574049
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (51.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Boston Scientific at 42.4% of the total. Reporting peaked in 2019 at $17,505 and has fallen 91.3% since, to $1,530 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in GA, where the typical reported total is $21,716.
Across 137 payments — averaging $167.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Medtronic$8K
- Abbott$3K
- Cvrx, Inc.$498
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$155
- Medical Device Business Services, Inc.$145
- plus $651 from 15 others
What the payments were for
- Grants$11,81851%
- Travel & lodging$4,45419%
- Food & beverage$6,22427%
- Education$4572%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $9,727 |
| Medtronic(2 entities) | 37 | $8,333 |
| Abbott | 40 | $3,444 |
| Cvrx, Inc. | 8 | $498 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $155 |
| Medical Device Business Services, Inc. | 3 | $145 |
| Biosense Webster, Inc. | 1 | $143 |
| Bayer | 1 | $120 |
| Edwards Lifesciences | 2 | $78 |
| Amarin Pharma, Inc. | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Pfizer | 2 | $39 |
| Johnson & Johnson | 2 | $35 |
| Abiomed | 1 | $29 |
| Impulse Dynamics (USA) Inc. | 2 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Amgen | 1 | $15 |
| Cordis US CORP. | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$6,750
- GENERAL - THERAPIES$1,144
- Ensite Cardiac Mapping System$1,065
- GENERAL TACHY$901
- Agilis NxT EP Introducer$471
- Barostim Neo System$363
- HeartMate 3 Left Ventricular Dev$172
- ENSITE$149
- FARAWAVE$145
- QDOT MICRO Catheter$143
- Quadra Assura CRT Defibrillator$139
- Micra$134
- Accent Pacemaker$131
- FINELINE II Sterox$125
- Kerendia$120
- ARTIC-L 3D TI SPINAL SYSTEM WITH TIONIC TECHNOLOGY$103
How this compares
$22,954 in reported general payments places this provider in the 50th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 510 | $508,245 |
| XareltoRivaroxaban | 59 | $77,122 |
| EntrestoSacubitril/Valsartan | 21 | $27,633 |
| Flecainide Acetate | 196 | $7,054 |
| Metoprolol Succinate | 550 | $7,028 |
| Dofetilide | 65 | $6,869 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $3,852 |
| Amiodarone Hcl | 139 | $3,072 |
| Sucralfate | 20 | $2,987 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 53 | $1,596 |
| Nifedipine ErNifedipine | 55 | $1,334 |
| Carvedilol | 172 | $1,126 |
| Hydralazine Hcl | 44 | $959 |
| Losartan Potassium | 103 | $896 |
| Metoprolol Tartrate | 160 | $679 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $39 | $508,245510 claims |
| Johnson & JohnsonXarelto | $35 | $77,12259 claims |
| NovartisEntresto | $13 | $27,63321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Stockbridge
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
- Alok GambhirGainesville$146K
- Joseph PokuMacon$130K
- Anand KeniaDalton$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.